Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in Lancet Neurol

Retrieve available abstracts of 52 articles:
HTML format
Text format



Single Articles


    September 2017
  1. JOSEPHS KA, Dickson DW, Tosakulwong N, Weigand SD, et al
    Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study.
    Lancet Neurol. 2017 Sep 11. pii: S1474-4422(17)30284.
    PubMed     Text format     Abstract available


  2. DROUIN E, Drouin G
    The first report of Alzheimer's disease.
    Lancet Neurol. 2017;16:687.
    PubMed     Text format    


    August 2017
  3. FRISONI GB, Boccardi M, Barkhof F, Blennow K, et al
    Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers.
    Lancet Neurol. 2017;16:661-676.
    PubMed     Text format     Abstract available


  4. COLEY N, Andrieu S
    Lessons from the Multidomain Alzheimer Preventive Trial - Authors' reply.
    Lancet Neurol. 2017;16:586.
    PubMed     Text format    


  5. YASSINE HN, Schneider LS
    Lessons from the Multidomain Alzheimer Preventive Trial.
    Lancet Neurol. 2017;16:585-586.
    PubMed     Text format    


  6. ESCOTT-PRICE V, Jones L
    Genomic profiling and diagnostic biomarkers in Alzheimer's disease.
    Lancet Neurol. 2017;16:582-583.
    PubMed     Text format    


  7. ISAAC MT, Vamvakas S, Isaac MB
    Diagnostic biomarkers for Alzheimer's disease: a regulatory view.
    Lancet Neurol. 2017;16:580-581.
    PubMed     Text format    


    June 2017
  8. KIRBY T
    Eric Reiman: aiming to prevent Alzheimer's disease.
    Lancet Neurol. 2017 Jun 30. pii: S1474-4422(17)30216.
    PubMed     Text format    


    May 2017
  9. HARDY J
    Membrane damage is at the core of Alzheimer's disease.
    Lancet Neurol. 2017;16:342.
    PubMed     Text format    


    April 2017
  10. VOSSEL KA, Tartaglia MC, Nygaard HB, Zeman AZ, et al
    Epileptic activity in Alzheimer's disease: causes and clinical relevance.
    Lancet Neurol. 2017;16:311-322.
    PubMed     Text format     Abstract available


    February 2017
  11. THE LANCET NEUROLOGY
    Solanezumab: too late in mild Alzheimer's disease?
    Lancet Neurol. 2017;16:97.
    PubMed     Text format    


    January 2017
  12. SCHNEIDER L
    Alzheimer's disease and other dementias: update on research.
    Lancet Neurol. 2017;16:4-5.
    PubMed     Text format    


  13. ATTEMS J
    Alzheimer's disease pathology in synucleinopathies.
    Lancet Neurol. 2017;16:22-23.
    PubMed     Text format    


  14. IRWIN DJ, Grossman M, Weintraub D, Hurtig HI, et al
    Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Lancet Neurol. 2017;16:55-65.
    PubMed     Text format     Abstract available


    December 2016
  15. PANZA F, Logroscino G
    Anti-tau vaccine in Alzheimer's disease: a tentative step.
    Lancet Neurol. 2016 Dec 9. pii: S1474-4422(16)30340.
    PubMed     Text format    


  16. NOVAK P, Schmidt R, Kontsekova E, Zilka N, et al
    Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial.
    Lancet Neurol. 2016 Dec 9. pii: S1474-4422(16)30331.
    PubMed     Text format     Abstract available


    October 2016
  17. RYAN NS, Nicholas JM, Weston PS, Liang Y, et al
    Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series.
    Lancet Neurol. 2016 Oct 21. pii: S1474-4422(16)30193.
    PubMed     Text format     Abstract available


  18. VAN DER FLIER WM
    Clinical heterogeneity in familial Alzheimer's disease.
    Lancet Neurol. 2016 Oct 21. pii: S1474-4422(16)30275.
    PubMed     Text format    


  19. TANG M, Ryman DC, McDade E, Jasielec MS, et al
    Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS).
    Lancet Neurol. 2016 Oct 21. pii: S1474-4422(16)30229.
    PubMed     Text format     Abstract available


    August 2016
  20. MORGAN J
    An orange and Alzheimer's disease?
    Lancet Neurol. 2016;15:911.
    PubMed     Text format    


    July 2016
  21. BISCHOF GN
    Alzheimer's disease risk: amyloid versus neurodegeneration.
    Lancet Neurol. 2016 Jul 19. pii: S1474-4422(16)30138.
    PubMed     Text format    


  22. BURNHAM SC, Bourgeat P, Dore V, Savage G, et al
    Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Lancet Neurol. 2016 Jul 19. pii: S1474-4422(16)30125.
    PubMed     Text format     Abstract available


  23. MORGAN J
    Early onset Alzheimer's disease: many mountains to climb.
    Lancet Neurol. 2016;15:798.
    PubMed     Text format    


  24. CUYVERS E, Sleegers K
    Genetic variations underlying Alzheimer's disease: evidence from genome-wide association studies and beyond.
    Lancet Neurol. 2016;15:857-68.
    PubMed     Text format     Abstract available


    June 2016
  25. NELSON PT
    Cerebrovascular pathology and Alzheimer's disease.
    Lancet Neurol. 2016 Jun 13. pii: S1474-4422(16)30038.
    PubMed     Text format    


  26. ARVANITAKIS Z, Capuano AW, Leurgans SE, Bennett DA, et al
    Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study.
    Lancet Neurol. 2016 Jun 13. pii: S1474-4422(16)30029.
    PubMed     Text format     Abstract available


  27. MORGAN J
    "A big decision": living with early onset familial Alzheimer's disease.
    Lancet Neurol. 2016;15:671.
    PubMed     Text format    


  28. TARIOT PN, Langbaum JB, Reiman EM
    What are we willing to accept for preventing Alzheimer's disease? - Investigators' reply.
    Lancet Neurol. 2016;15:660-1.
    PubMed     Text format    


  29. CESARI M, Vanacore N, Canevelli M
    What are we willing to accept for preventing Alzheimer's disease?
    Lancet Neurol. 2016;15:659-60.
    PubMed     Text format    


  30. FRISONI GB, Hansson O
    Clinical validity of CSF biomarkers for Alzheimer's disease: necessary indeed, but sufficient?
    Lancet Neurol. 2016;15:650-1.
    PubMed     Text format    


  31. THE LANCET NEUROLOGY
    Finding a cure for Alzheimer's disease starts with prevention.
    Lancet Neurol. 2016;15:649.
    PubMed     Text format    


    April 2016
  32. OLSSON B, Lautner R, Andreasson U, Ohrfelt A, et al
    CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
    Lancet Neurol. 2016 Apr 8. pii: S1474-4422(16)00070.
    PubMed     Text format     Abstract available


  33. WINBLAD B, Amouyel P, Andrieu S, Ballard C, et al
    Defeating Alzheimer's disease and other dementias: a priority for European science and society.
    Lancet Neurol. 2016;15:455-532.
    PubMed     Text format    


  34. MAZURE CM, Swendsen J
    Sex differences in Alzheimer's disease and other dementias.
    Lancet Neurol. 2016;15:451-2.
    PubMed     Text format    


  35. QUAGLIO G, Brand H, Dario C
    Fighting dementia in Europe: the time to act is now.
    Lancet Neurol. 2016;15:452-4.
    PubMed     Text format    


    December 2015
  36. WRAY S, Fox NC
    Stem cell therapy for Alzheimer's disease: hope or hype?
    Lancet Neurol. 2015 Dec 15. pii: S1474-4422(15)00382.
    PubMed     Text format    


  37. HUNSBERGER JG, Rao M, Kurtzberg J, Bulte JW, et al
    Accelerating stem cell trials for Alzheimer's disease.
    Lancet Neurol. 2015 Dec 15. pii: S1474-4422(15)00332.
    PubMed     Text format     Abstract available


    November 2015
  38. VOS SJ, Fagan AM
    Alzheimer's disease biomarker states.
    Lancet Neurol. 2015 Nov 17. pii: S1474-4422(15)00335.
    PubMed     Text format    


    October 2015
  39. HOWARD R, McShane R, Lindesay J, Ritchie C, et al
    Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses.
    Lancet Neurol. 2015 Oct 26. pii: S1474-4422(15)00258.
    PubMed     Text format     Abstract available


  40. WIMO A
    Long-term effects of Alzheimer's disease treatment.
    Lancet Neurol. 2015 Oct 26. pii: S1474-4422(15)00302.
    PubMed     Text format    


    September 2015
  41. LAUNER LJ
    Preventing Alzheimer's disease is difficult.
    Lancet Neurol. 2015;14:872-4.
    PubMed     Text format    


    August 2015
  42. TEIPEL S, Drzezga A, Grothe MJ, Barthel H, et al
    Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection.
    Lancet Neurol. 2015 Aug 26. pii: S1474-4422(15)00093.
    PubMed     Text format     Abstract available


  43. GROSSMAN M
    Integrated multimodal imaging in neurodegenerative disease.
    Lancet Neurol. 2015 Aug 26. pii: S1474-4422(15)00182.
    PubMed     Text format    


  44. KIRBY T
    William Klunk: imaging Alzheimer's disease in vivo.
    Lancet Neurol. 2015;14:791.
    PubMed     Text format    


  45. THE LANCET NEUROLOGY
    Alzheimer's disease: a time for cautious optimism.
    Lancet Neurol. 2015;14:779.
    PubMed     Text format    


    July 2015
  46. ANDRIEU S, Coley N, Lovestone S, Aisen PS, et al
    Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions.
    Lancet Neurol. 2015 Jul 23. pii: S1474-4422(15)00153.
    PubMed     Text format     Abstract available


  47. BIANCHI A
    Sir Terry Pratchett: shaking hands with Death.
    Lancet Neurol. 2015;14:691.
    PubMed     Text format    


    June 2015
  48. FARRER LA
    Expanding the genomic roadmap of Alzheimer's disease.
    Lancet Neurol. 2015 Jun 30. pii: S1474-4422(15)00146.
    PubMed     Text format    


  49. CUYVERS E, De Roeck A, Van den Bossche T, Van Cauwenberghe C, et al
    Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study.
    Lancet Neurol. 2015 Jun 30. pii: S1474-4422(15)00133.
    PubMed     Text format     Abstract available


  50. FRISONI GB, Visser PJ
    Biomarkers for Alzheimer's disease: a controversial topic.
    Lancet Neurol. 2015 Jun 29. pii: S1474-4422(15)00150.
    PubMed     Text format    


  51. YAU WW, Tudorascu DL, McDade EM, Ikonomovic S, et al
    Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study.
    Lancet Neurol. 2015 Jun 29. pii: S1474-4422(15)00135.
    PubMed     Text format     Abstract available


    May 2015
  52. HOLMES D
    Stuart Lipton: UFOs and flying tigers.
    Lancet Neurol. 2015;14:464.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: